These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 11289470)

  • 1. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
    Reis AF; Hani EH; Beressi N; Robert JJ; Bresson JL; Froguel P; Velho G
    Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
    Rissanen J; Markkanen A; Kärkkäinen P; Pihlajamäki J; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Laakso M
    Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
    Gloyn AL; Weedon MN; Owen KR; Turner MJ; Knight BA; Hitman G; Walker M; Levy JC; Sampson M; Halford S; McCarthy MI; Hattersley AT; Frayling TM
    Diabetes; 2003 Feb; 52(2):568-72. PubMed ID: 12540637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):317-21. PubMed ID: 17516295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes.
    Chistiakov DA; Potapov VA; Khodirev DC; Shamkhalova MS; Shestakova MV; Nosikov VV
    Acta Diabetol; 2009 Mar; 46(1):43-9. PubMed ID: 18758683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population.
    Gonen MS; Arikoglu H; Erkoc Kaya D; Ozdemir H; Ipekci SH; Arslan A; Kayis SA; Gogebakan B
    Arch Med Res; 2012 May; 43(4):317-23. PubMed ID: 22704848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
    Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O
    Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.
    Florez JC; Burtt N; de Bakker PI; Almgren P; Tuomi T; Holmkvist J; Gaudet D; Hudson TJ; Schaffner SF; Daly MJ; Hirschhorn JN; Groop L; Altshuler D
    Diabetes; 2004 May; 53(5):1360-8. PubMed ID: 15111507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses.
    van Dam RM; Hoebee B; Seidell JC; Schaap MM; de Bruin TW; Feskens EJ
    Diabet Med; 2005 May; 22(5):590-8. PubMed ID: 15842514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects.
    Yokoi N; Kanamori M; Horikawa Y; Takeda J; Sanke T; Furuta H; Nanjo K; Mori H; Kasuga M; Hara K; Kadowaki T; Tanizawa Y; Oka Y; Iwami Y; Ohgawara H; Yamada Y; Seino Y; Yano H; Cox NJ; Seino S
    Diabetes; 2006 Aug; 55(8):2379-86. PubMed ID: 16873704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
    Elbein SC; Wegner K; Kahn SE
    Diabetes Care; 2000 Feb; 23(2):221-7. PubMed ID: 10868835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
    Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
    Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D
    Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.